News
Videos
Conferences
Events
Resources
Subscribe

|Videos|June 29, 2022

Future Perspectives in Renal Cell Carcinoma (RCC)

Author(s)Thomas Hutson, DO, PharmD

Dr Thomas Hutson comments on the TiNivo-2 trial and discusses upcoming and novel therapies for patients with renal cell carcinoma.

Episodes in this series

EP. 1 Treatment Options for Patients with Renal Cell Carcinoma (RCC)

EP. 1 Treatment Options for Patients with Renal Cell Carcinoma (RCC)

EP. 2 Clinical Implications of the TIVO-3 Trial

EP. 2 Clinical Implications of the TIVO-3 Trial

EP. 3 Tivozanib: Adverse Event Profile and How Toxicities are Managed

EP. 4 Experience with Tivozanib in the 3rd Line Setting for Patients with RCC

EP. 4 Experience with Tivozanib in the 3rd Line Setting for Patients with RCC

EP. 5 Future Perspectives in Renal Cell Carcinoma (RCC)

EP. 5 Future Perspectives in Renal Cell Carcinoma (RCC)

Newsletter

Stay up to date on cancer updates, research and education

Related Content

image of woman.

New Book Spotlights Cancer in Early Adulthood

ByCristina Pozo-Kaderman

November 5th 2025

Image of woman.

Community of Support Available for Patients With Cancer

ByAlyson B. Moadel-Robblee

October 28th 2025

kidney cancer

Fruzaqla and Tyvyt Combo Shows Improved Outcomes in Advanced Kidney Cancer

October 14th 2025

Dr. Ravi Munver

Helping Patients Understand the Evolving Landscape of Kidney Cancer Treatment

October 11th 2025

Image of man.

Minimally Invasive Kidney Cancer Treatments Boosts Patient Recovery

ByDr. Ravi Munver

October 9th 2025

Trending on CURE

Top Blood Cancer Stories from October: Key Updates for Patients

Understanding Your Diagnosis of Bile Duct Cancer

Shining a Spotlight on Pinups4Cancer

Understanding Your Stage 2 Uterine (Endometrial) Cancer

Barbie, Breast Cancer and the Power of Dolls in Healing

© 2025 MJH Life Sciences^®

All rights reserved.